메뉴 건너뛰기




Volumn 1413, Issue , 2011, Pages 72-83

Effects of the novel glycopeptide opioid agonist MMP-2200 in preclinical models of Parkinson's disease

Author keywords

Opioid receptor; Opioid receptor; 6 OHDA; Akinesia; Dopaminergic hyper stimulation; Reserpine

Indexed keywords

ANTIPARKINSON AGENT; APOMORPHINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; MMP 2200; MU OPIATE RECEPTOR AGONIST; NALOXONE; NALTRINDOLE; UNCLASSIFIED DRUG;

EID: 80052507409     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.07.038     Document Type: Article
Times cited : (15)

References (43)
  • 2
    • 26844505808 scopus 로고    scopus 로고
    • Toxin-induced models of Parkinson's disease
    • DOI 10.1602/neurorx.2.3.484
    • J. Bové, D. Prou, C. Perier, and S. Przedborski Toxin-induced models of Parkinson's disease NeuroRx 2 2005 484 494 (Pubitemid 41444882)
    • (2005) NeuroRx , vol.2 , Issue.3 , pp. 484-494
    • Bove, J.1    Prou, D.2    Perier, C.3    Przedborski, S.4
  • 5
    • 0031925945 scopus 로고    scopus 로고
    • L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA
    • DOI 10.1046/j.1460-9568.1998.00285.x
    • M.A. Cenci, C.S. Lee, and A. Bjorklund l-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA Eur. J. Neurosci. 10 1998 2694 2706 (Pubitemid 28362576)
    • (1998) European Journal of Neuroscience , vol.10 , Issue.8 , pp. 2694-2706
    • Cenci, M.A.1    Lee, C.S.2    Bjorklund, A.3
  • 6
    • 0027332132 scopus 로고
    • BW373U86: A nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells
    • S.R. Childers, L.M. Fleming, D.E. Selley, R.W. McNutt, and K.J. Chang BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells Mol. Pharmacol. 44 1993 827 834
    • (1993) Mol. Pharmacol. , vol.44 , pp. 827-834
    • Childers, S.R.1    Fleming, L.M.2    Selley, D.E.3    McNutt, R.W.4    Chang, K.J.5
  • 7
    • 0017927926 scopus 로고
    • Evidence for a long Leu-enkephalin striopallidal pathway in rat brain
    • A.C. Cuello, and G. Paxinos Evidence for a long Leu-enkephalin striopallidal pathway in rat brain Nature 271 1978 178 180 (Pubitemid 8251637)
    • (1978) Nature , vol.271 , Issue.5641 , pp. 178-180
    • Cuello, A.C.1    Paxinos, G.2
  • 8
    • 33947302427 scopus 로고    scopus 로고
    • Modulation of l-DOPA-induced abnormal involuntary movements by clinically tested compounds: Further validation of the rat dyskinesia model
    • DOI 10.1016/j.bbr.2007.01.013, PII S0166432807000460
    • A. Dekundy, M. Lundblad, W. Danysz, and M.A. Cenci Modulation of l-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model Behav. Brain Res. 179 2007 76 89 (Pubitemid 46441485)
    • (2007) Behavioural Brain Research , vol.179 , Issue.1 , pp. 76-89
    • Dekundy, A.1    Lundblad, M.2    Danysz, W.3    Cenci, M.A.4
  • 9
    • 53849119185 scopus 로고    scopus 로고
    • Behavioral pharmacology of the mu/delta opioid glycopeptide MMP2200 in rhesus monkeys
    • G.P. Do Carmo, R. Polt, E.J. Bilsky, K.C. Rice, and S.S. Negus Behavioral pharmacology of the mu/delta opioid glycopeptide MMP2200 in rhesus monkeys J. Pharmacol. Exp. Ther. 326 2008 939 948
    • (2008) J. Pharmacol. Exp. Ther. , vol.326 , pp. 939-948
    • Do Carmo, G.P.1    Polt, R.2    Bilsky, E.J.3    Rice, K.C.4    Negus, S.S.5
  • 10
    • 0031128414 scopus 로고    scopus 로고
    • Enhancement of the behavioral response to apomorphine administration following repeated treatment in the 6-hydroxydopamine-lesioned rat is temporally correlated with a rise in striatal preproenkephalin-B, but not preproenkephalin-A, gene expression
    • DOI 10.1006/exnr.1997.6431
    • S. Duty, and J.M. Brotchie Enhancement of the behavioral response to apomorphine administration following repeated treatment in the 6-hydroxydopamine-lesioned rat is temporally correlated with a rise in striatal preproenkephalin-B, but not preproenkephalin-A, gene expression Exp. Neurol. 144 1997 423 432 (Pubitemid 27224570)
    • (1997) Experimental Neurology , vol.144 , Issue.2 , pp. 423-432
    • Duty, S.1    Brotchie, J.M.2
  • 14
    • 0025765058 scopus 로고
    • Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats
    • T.M. Engber, Z. Susel, S. Kuo, C.R. Gerfen, and T.N. Chase Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats Brain Res. 552 1991 113 118
    • (1991) Brain Res. , vol.552 , pp. 113-118
    • Engber, T.M.1    Susel, Z.2    Kuo, S.3    Gerfen, C.R.4    Chase, T.N.5
  • 15
    • 79955595805 scopus 로고    scopus 로고
    • Vascular endothelial growth factor B is neuroprotective in an in vivo model of Parkinson's disease
    • T. Falk, X. Yue, S.L. Zhang, A.D. McCourt, B.J. Yee, R.T. Gonzalez, and S.J. Sherman Vascular endothelial growth factor B is neuroprotective in an in vivo model of Parkinson's disease Neurosci. Lett. 496 2011 43 47
    • (2011) Neurosci. Lett. , vol.496 , pp. 43-47
    • Falk, T.1    Yue, X.2    Zhang, S.L.3    McCourt, A.D.4    Yee, B.J.5    Gonzalez, R.T.6    Sherman, S.J.7
  • 16
    • 4544255049 scopus 로고    scopus 로고
    • Non-subtype-selective opioid receptor antagonism in treatment of levodopa-induced motor complications in Parkinson's disease
    • S. Fox, M. Silverdale, M. Kellett, R. Davies, M. Steiger, N. Fletcher, A. Crossman, and J. Brotchie Non-subtype-selective opioid receptor antagonism in treatment of levodopa-induced motor complications in Parkinson's disease Mov. Disord. 19 2004 554 560
    • (2004) Mov. Disord. , vol.19 , pp. 554-560
    • Fox, S.1    Silverdale, M.2    Kellett, M.3    Davies, R.4    Steiger, M.5    Fletcher, N.6    Crossman, A.7    Brotchie, J.8
  • 17
    • 33750990196 scopus 로고    scopus 로고
    • Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies: Keys to success and roads to failure
    • DOI 10.1002/mds.20936
    • S.H. Fox, A.E. Lang, and J.M. Brotchie Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies: keys to success and roads to failure Mov. Disord. 21 2006 1578 1594 (Pubitemid 44742184)
    • (2006) Movement Disorders , vol.21 , Issue.10 , pp. 1578-1594
    • Fox, S.H.1    Lang, A.E.2    Brotchie, J.M.3
  • 18
    • 84886635094 scopus 로고
    • Enhancement of reserpine-elicited dopaminergic supersensitivity by repeated treatment with apomorphine and alpha-methyl-p-tyrosine
    • E. Friedman, J. Rotrosen, M. Gurland, G.A. Lambert, and S. Gershon Enhancement of reserpine-elicited dopaminergic supersensitivity by repeated treatment with apomorphine and alpha-methyl-p-tyrosine Life Sci. 17 1975 867 873
    • (1975) Life Sci. , vol.17 , pp. 867-873
    • Friedman, E.1    Rotrosen, J.2    Gurland, M.3    Lambert, G.A.4    Gershon, S.5
  • 19
    • 4644264252 scopus 로고    scopus 로고
    • Mixed opioid receptor agonists as a new class of agents for the treatment of moderate to severe pain
    • K.-J. Chang, F. Porreca, J.H. Woods, Marcel Dekker, Inc New York
    • P.J. Gengo, and K.-J. Chang Mixed opioid receptor agonists as a new class of agents for the treatment of moderate to severe pain K.-J. Chang, F. Porreca, J.H. Woods, The Delta Receptor 2004 Marcel Dekker, Inc New York 231 244
    • (2004) The Delta Receptor , pp. 231-244
    • Gengo, P.J.1    Chang, K.-J.2
  • 20
    • 0026531301 scopus 로고
    • The neostriatal mosaic: Multiple levels of compartmental organization
    • C.R. Gerfen The neostriatal mosaic: multiple levels of compartmental organization Trends Neurosci. 15 1992 133 139
    • (1992) Trends Neurosci. , vol.15 , pp. 133-139
    • Gerfen, C.R.1
  • 21
    • 0027384928 scopus 로고
    • Effect of nondopaminergic drugs on L-DOPA-induced dyskinesias in MPTP- treated monkeys
    • B. Gomez-Mancilla, and P.J. Bedard Effect of nondopaminergic drugs on l-dopa-induced dyskinesias in MPTP-treated monkeys Clin. Neuropharmacol. 16 1993 418 427 (Pubitemid 23292096)
    • (1993) Clinical Neuropharmacology , vol.16 , Issue.5 , pp. 418-427
    • Gomez-Mancilla, B.1    Bedard, P.J.2
  • 22
    • 0033010166 scopus 로고    scopus 로고
    • Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat
    • DOI 10.1006/exnr.1998.6996
    • B. Henry, A.R. Crossman, and J.M. Brotchie Effect of repeated l-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat Exp. Neurol. 155 1999 204 220 (Pubitemid 29124714)
    • (1999) Experimental Neurology , vol.155 , Issue.2 , pp. 204-220
    • Henry, B.1    Crossman, A.R.2    Brotchie, J.M.3
  • 23
    • 0034851915 scopus 로고    scopus 로고
    • μ- and δ-Opioid receptor antagonists reduce levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease
    • DOI 10.1006/exnr.2001.7727
    • B. Henry, S.H. Fox, A.R. Crossman, and J.M. Brotchie Mu- and delta-opioid receptor antagonists reduce levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease Exp. Neurol. 171 2001 139 146 (Pubitemid 32848452)
    • (2001) Experimental Neurology , vol.171 , Issue.1 , pp. 139-146
    • Henry, B.1    Fox, S.H.2    Crossman, A.R.3    Brotchie, J.M.4
  • 24
    • 0141672033 scopus 로고    scopus 로고
    • Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease
    • DOI 10.1016/S0014-4886(03)00064-5
    • B. Henry, S. Duty, S.H. Fox, A.R. Crossman, and J.M. Brotchie Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease Exp. Neurol. 183 2003 458 468 (Pubitemid 37205087)
    • (2003) Experimental Neurology , vol.183 , Issue.2 , pp. 458-468
    • Henry, B.1    Duty, S.2    Fox, S.H.3    Crossman, A.R.4    Brotchie, J.M.5
  • 25
    • 0035204775 scopus 로고    scopus 로고
    • Antiparkinsonian action of a δ opioid agonist in rodent and primate models of Parkinson's disease
    • DOI 10.1006/exnr.2001.7763
    • C.J. Hille, S.H. Fox, Y.P. Maneuf, A.R. Crossman, and J.M. Brotchie Antiparkinsonian action of a delta opioid agonist in rodent and primate models of Parkinson's disease Exp. Neurol. 172 2001 189 198 (Pubitemid 33143821)
    • (2001) Experimental Neurology , vol.172 , Issue.1 , pp. 189-198
    • Hille, C.J.1    Fox, S.H.2    Maneuf, Y.P.3    Crossman, A.R.4    Brotchie, J.M.5
  • 26
    • 0034685961 scopus 로고    scopus 로고
    • Antiparkinson potential of δ-opioid receptor agonists
    • DOI 10.1016/S0014-2999(00)00209-0, PII S0014299900002090
    • T.J. Hudzik, A. Howell, K. Payza, and A.J. Cross Antiparkinson potential of delta-opioid receptor agonists Eur. J. Pharmacol. 396 2000 101 107 (Pubitemid 30265565)
    • (2000) European Journal of Pharmacology , vol.396 , Issue.2-3 , pp. 101-107
    • Hudzik, T.J.1    Howell, A.2    Payza, K.3    Cross, A.J.4
  • 27
    • 0036387577 scopus 로고    scopus 로고
    • Naloxone reduces levodopa-induced dyskinesias and apomorphine-induced rotations in primate models of parkinsonism
    • R. Klintenberg, P. Svenningsson, L. Gunne, and P.E. Andren Naloxone reduces levodopa-induced dyskinesias and apomorphine-induced rotations in primate models of parkinsonism J. Neural Transm. 109 2002 1295 1307
    • (2002) J. Neural Transm. , vol.109 , pp. 1295-1307
    • Klintenberg, R.1    Svenningsson, P.2    Gunne, L.3    Andren, P.E.4
  • 28
    • 85057699443 scopus 로고    scopus 로고
    • Biphalin: A multireceptor opioid ligand
    • K.-J. Chang, F. Porreca, J.H. Woods, Marcel Dekker, Inc New York
    • A.W. Lipkowski, D.B. Carr, I. Bonney, and A. Misicka Biphalin: a multireceptor opioid ligand K.-J. Chang, F. Porreca, J.H. Woods, The Delta Receptor 2004 Marcel Dekker, Inc New York 245 261
    • (2004) The Delta Receptor , pp. 245-261
    • Lipkowski, A.W.1    Carr, D.B.2    Bonney, I.3    Misicka, A.4
  • 32
    • 0028908280 scopus 로고
    • Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease
    • A.P. Nisbet, O.J. Foster, A. Kingsbury, D.J. Eve, S.E. Daniel, C.D. Marsden, and A.J. Lees Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease Neuroscience 66 1995 361 376
    • (1995) Neuroscience , vol.66 , pp. 361-376
    • Nisbet, A.P.1    Foster, O.J.2    Kingsbury, A.3    Eve, D.J.4    Daniel, S.E.5    Marsden, C.D.6    Lees, A.J.7
  • 34
    • 66949117423 scopus 로고    scopus 로고
    • The scientific and clinical basis for the treatment of Parkinson disease (2009)
    • C.W. Olanow, M.B. Stern, and K. Sethi The scientific and clinical basis for the treatment of Parkinson disease (2009) Neurology 72 2009 S1 S136
    • (2009) Neurology , vol.72
    • Olanow, C.W.1    Stern, M.B.2    Sethi, K.3
  • 37
    • 0035990392 scopus 로고    scopus 로고
    • Safety and efficacy of controlled-release oxycodone: A systematic literature review
    • D.G. Rischitelli, and S.H. Karbowicz Safety and efficacy of controlled-release oxycodone: a systematic literature review Pharmacotherapy 22 2002 898 904 (Pubitemid 34743439)
    • (2002) Pharmacotherapy , vol.22 , Issue.7 , pp. 898-904
    • Rischitelli, D.G.1    Karbowicz, S.H.2
  • 38
    • 0142122419 scopus 로고    scopus 로고
    • Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: Interaction between dopamine and opioid systems
    • DOI 10.1016/S0028-3908(03)00249-1
    • P. Samadi, L. Gregoire, and P.J. Bedard Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: interaction between dopamine and opioid systems Neuropharmacology 45 2003 954 963 (Pubitemid 37297921)
    • (2003) Neuropharmacology , vol.45 , Issue.7 , pp. 954-963
    • Samadi, P.1    Gregoire, L.2    Bedard, P.J.3
  • 39
    • 33748683820 scopus 로고    scopus 로고
    • Opioids and motor complications in Parkinson's disease
    • DOI 10.1016/j.tips.2006.08.002, PII S0165614706001829
    • P. Samadi, P.J. Bedard, and C. Rouillard Opioids and motor complications in Parkinson's disease Trends Pharmacol. Sci. 27 2006 512 517 (Pubitemid 44389881)
    • (2006) Trends in Pharmacological Sciences , vol.27 , Issue.10 , pp. 512-517
    • Samadi, P.1    Bedard, P.J.2    Rouillard, C.3
  • 40
    • 0028220834 scopus 로고
    • Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat
    • DOI 10.1016/0306-4522(94)90605-X
    • H. Sauer, and W.H. Oertel Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat Neuroscience 59 1994 401 415 (Pubitemid 24098798)
    • (1994) Neuroscience , vol.59 , Issue.2 , pp. 401-415
    • Sauer, H.1    Oertel, W.H.2
  • 41
    • 33745847479 scopus 로고    scopus 로고
    • Diagnosis and treatment of Parkinson disease: Molecules to medicine
    • DOI 10.1172/JCI29178
    • J.M. Savitt, V.L. Dawson, and T.M. Dawson Diagnosis and treatment of Parkinson disease: molecules to medicine J. Clin. Investig. 116 2006 1744 1754 (Pubitemid 44033293)
    • (2006) Journal of Clinical Investigation , vol.116 , Issue.7 , pp. 1744-1754
    • Savitt, J.M.1    Dawson, V.L.2    Dawson, T.M.3
  • 42
    • 0022516918 scopus 로고
    • Two automated locomotor activity tests for dopamine autoreceptor agonists
    • P.J. Schreur, and N.F. Nichols Two automated locomotor activity tests for dopamine autoreceptor agonists Pharmacol. Biochem. Behav. 25 1986 255 261 (Pubitemid 16040934)
    • (1986) Pharmacology Biochemistry and Behavior , vol.25 , Issue.1 , pp. 255-261
    • Schreur, P.J.K.D.1    Nichols, N.F.2
  • 43
    • 0021325819 scopus 로고
    • Evidence for a selective processing of proenkephalin B into different opioid peptide forms in particular regions of rat brain and pituitary
    • B.R. Seizinger, C. Grimm, V. Hollt, and A. Herz Evidence for a selective processing of proenkephalin B into different opioid peptide forms in particular regions of rat brain and pituitary J. Neurochem. 42 1984 447 457 (Pubitemid 14180779)
    • (1984) Journal of Neurochemistry , vol.42 , Issue.2 , pp. 447-457
    • Seizinger, B.R.1    Grimm, C.2    Hollt, V.3    Herz, A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.